ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $12,166 | -28.4% | 563 | -37.4% | 0.00% | – |
| Q3 2022 | $17,000 | -98.6% | 900 | -98.5% | 0.00% | -100.0% |
| Q2 2022 | $1,178,000 | +351.3% | 59,323 | +579.0% | 0.00% | – |
| Q1 2022 | $261,000 | -78.5% | 8,737 | -83.3% | 0.00% | -100.0% |
| Q4 2021 | $1,215,000 | +38.5% | 52,186 | +85.7% | 0.00% | 0.0% |
| Q3 2021 | $877,000 | -46.3% | 28,099 | -39.5% | 0.00% | 0.0% |
| Q2 2021 | $1,634,000 | -24.2% | 46,446 | -24.0% | 0.00% | 0.0% |
| Q1 2021 | $2,155,000 | +1557.7% | 61,133 | +1669.9% | 0.00% | – |
| Q4 2020 | $130,000 | +490.9% | 3,454 | +435.5% | 0.00% | – |
| Q3 2020 | $22,000 | -54.2% | 645 | -64.1% | 0.00% | – |
| Q2 2020 | $48,000 | -5.9% | 1,797 | -41.9% | 0.00% | – |
| Q1 2020 | $51,000 | -7.3% | 3,093 | +41.8% | 0.00% | – |
| Q4 2019 | $55,000 | +111.5% | 2,182 | +68.0% | 0.00% | – |
| Q3 2019 | $26,000 | -72.3% | 1,299 | -55.1% | 0.00% | – |
| Q2 2019 | $94,000 | +27.0% | 2,893 | +25.7% | 0.00% | – |
| Q1 2019 | $74,000 | +23.3% | 2,302 | -5.6% | 0.00% | – |
| Q4 2018 | $60,000 | -26.8% | 2,439 | -2.5% | 0.00% | – |
| Q3 2018 | $82,000 | +34.4% | 2,502 | +46.5% | 0.00% | – |
| Q2 2018 | $61,000 | – | 1,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |